Advances in transcutaneous vaccine delivery: Do all ways lead to Rome? (Q37792508)

23 August 2017

title

Advances in transcutaneous vaccine delivery: do all ways lead to Rome? (English)

1 reference

23 August 2017

Advances in transcutaneous vaccine delivery: Do all ways lead to Rome? (English)

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

20 July 2024

0 references

1 reference

4

Wim Jiskoot

1 reference

23 August 2017

5

Joke A Bouwstra

1 reference

23 August 2017

1

Suzanne M. Bal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20869998

20 July 2024

author name string

Zhi Ding

2

1 reference

23 August 2017

Elly van Riet

3

1 reference

23 August 2017

Joke A. Bouwstra

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20869998

20 July 2024

language of work or name

English

0 references

publication date

24 September 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0168365910007832?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

https://api.elsevier.com/content/article/PII:S0168365910007832?httpAccept=text/plain

20 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Journal of Controlled Release

20 July 2024

published in

1 reference

23 August 2017

volume

148

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

266-282

1 reference

Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells

23 August 2017

cites work

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1038/NI.1770

Vaccines in historic evolution and perspective: a narrative of vaccine discoveries

1

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Immunological concepts of vaccine adjuvant activity

20 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Vaccine adjuvants: current challenges and future approaches.

20 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Making vaccines more acceptable--methods to prevent and minimize pain and other common adverse events associated with vaccines.

20 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Rational design of nasal vaccines

20 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook

20 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Oral vaccine delivery--new strategies and technologies

20 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Pulmonary vaccine delivery

20 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Immune surveillance in the skin: mechanisms and clinical consequences

20 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Vaccine allergy and pseudo-allergy

20 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

The 500 Dalton rule for the skin penetration of chemical compounds and drugs

20 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Terminal differentiation of epidermal keratinocytes

20 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Defining protective responses to pathogens: cytokine profiles in leprosy lesions

20 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

The danger model: a renewed sense of self

20 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Role of Langerhans cells in cutaneous protective immunity: is the reappraisal necessary?

20 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Decision-making at the surface of the intact or barrier disrupted skin: potential applications for vaccination or therapy

20 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Langerhans cells--revisiting the paradigm using genetically engineered mice

20 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Eosinophilic pustular folliculitis successfully treated with sequential therapy of interferon-gamma and ciclosporin

20 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Expression of the C-C chemokine MIP-3 alpha/CCL20 in human epidermis with impaired permeability barrier function

20 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors.

20 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes

20 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Two way communication between neutrophils and dendritic cells

20 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α

20 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin

20 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Dendritic cells and the control of immunity

20 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Pathogen recognition and innate immunity

20 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

20 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Triggering TLR signaling in vaccination

20 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments

20 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition

20 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria

20 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines

20 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent.

20 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes

20 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

TGF-alpha regulates TLR expression and function on epidermal keratinocytes

20 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9

20 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Cultured human melanocytes express functional toll-like receptors 2-4, 7 and 9

20 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Toll-like receptors in the skin

20 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Dendritic cell subsets in health and disease.

20 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Toll-like receptor 7-induced immune response to cutaneous West Nile virus infection

20 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Differential expression and function of Toll-like receptors in Langerhans cells: comparison with splenic dendritic cells

20 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

TLR-ligand stimulated interleukin-23 subunit expression and assembly is regulated differentially in murine plasmacytoid and myeloid dendritic cells.

20 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Dendritic cells at the host-pathogen interface.

20 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals.

20 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Pyogenic bacterial infections in humans with MyD88 deficiency

20 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

CATERPILLER: a novel gene family important in immunity, cell death, and diseases

20 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

NLRs join TLRs as innate sensors of pathogens

20 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Peptidoglycan signaling in innate immunity and inflammatory disease

20 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

20 July 2024

Toll-free immunity?

53

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

C-type lectin receptors on dendritic cells and Langerhans cells

20 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Self- and nonself-recognition by C-type lectins on dendritic cells

20 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Dendritic-cell control of pathogen-driven T-cell polarization

20 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Innate immune recognition

20 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights.

20 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

20 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells

20 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage

20 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells

20 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.

20 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells

20 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells.

20 July 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

20 July 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

The influence of antigen organization on B cell responsiveness

20 July 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Studies of the humoral immune response

20 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity

20 July 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

The vast majority of CLA+ T cells are resident in normal skin.

20 July 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans

20 July 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity

20 July 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus

20 July 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Skin-resident T cells: the ups and downs of on site immunity

20 July 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors

20 July 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response

20 July 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

20 July 2024

Innate immunity

78

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Toll-like receptors and innate immunity

20 July 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Innate immunity: impact on the adaptive immune response

20 July 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Skin immune sentinels in health and disease

20 July 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Dendritic cell subsets in primary and secondary T cell responses at body surfaces

20 July 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules

20 July 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

CD1-restricted T cell recognition of microbial lipoglycan antigens

20 July 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Cutaneous dendritic cells

20 July 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages

20 July 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells

20 July 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state

20 July 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Identification of a novel population of Langerin+ dendritic cells

20 July 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells

20 July 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes

20 July 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions

20 July 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells

20 July 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells

20 July 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses

20 July 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

CD14+ antigen-presenting cells in human dermis are less mature than their CD1a+ counterparts

20 July 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

CD34+ Hematopoietic Progenitors From Human Cord Blood Differentiate Along Two Independent Dendritic Cell Pathways in Response to Granulocyte-Macrophage Colony-Stimulating Factor Plus Tumor Necrosis Factor α: II. Functional Analysis

20 July 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity

20 July 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells.

20 July 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Mature Human Langerhans Cells Derived from CD34+ Hematopoietic Progenitors Stimulate Greater Cytolytic T Lymphocyte Activity in the Absence of Bioactive IL-12p70, by Either Single Peptide Presentation or Cross-Priming, Than Do Dermal-Interstitial or

20 July 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Harnessing human dendritic cell subsets to design novel vaccines

20 July 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Most lymphoid organ dendritic cell types are phenotypically and functionally immature.

20 July 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection

20 July 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres

20 July 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid

20 July 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Hepatitis A vaccine administration: comparison between jet-injector and needle injection

20 July 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins

20 July 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Manipulating the immune system: humoral versus cell-mediated immunity

20 July 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM.

20 July 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Skin immunization made possible by cholera toxin

20 July 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Principles of transcutaneous immunization using cholera toxin as an adjuvant

20 July 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge

20 July 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Immunization onto shaved skin with a bacterial enterotoxin adjuvant protects mice against respiratory syncytial virus (RSV).

20 July 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Optimization of epicutaneous immunization for the induction of CTL.

20 July 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants

20 July 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transcutaneous immunization: T cell responses and boosting of existing immunity

20 July 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transcutaneous immunization with tetanus toxoid and mutants of Escherichia coli heat-labile enterotoxin as adjuvants elicits strong protective antibody responses.

20 July 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

The LTR72 mutant of heat-labile enterotoxin of Escherichia coli enhances the ability of peptide antigens to elicit CD4(+) T cells and secrete gamma interferon after coapplication onto bare skin

20 July 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

B subunit of E. coli enterotoxin as adjuvant and carrier in oral and skin vaccination

20 July 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Immune modulation by adjuvants combined with diphtheria toxoid administered topically in BALB/c mice after microneedle array pretreatment

20 July 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice.

20 July 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transcutaneous immunization with cross-reacting material CRM(197) of diphtheria toxin boosts functional antibody levels in mice primed parenterally with adsorbed diphtheria toxoid vaccine

20 July 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transcutaneous immunization with inactivated influenza virus induces protective immune responses

20 July 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations

20 July 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4+ T cells

20 July 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses

20 July 2024

132

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

A peptide vaccine administered transcutaneously together with cholera toxin elicits potent neutralising anti-FMDV antibody responses

20 July 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Differential signaling by CpG DNA in DCs and B cells: not just TLR9

20 July 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres

20 July 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

A Toll-like receptor recognizes bacterial DNA

20 July 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Cross-reactive protection against influenza A virus by a topically applied DNA vaccine encoding M gene with adjuvant

20 July 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

CpG motifs induce Langerhans cell migration in vivo

20 July 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Bacterial DNA and CpG-containing oligodeoxynucleotides activate cutaneous dendritic cells and induce IL-12 production: implications for the augmentation of Th1 responses

20 July 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Adjuvantation of epidermal powder immunization

20 July 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12

20 July 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells

20 July 2024

142

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

20 July 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study

20 July 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers

20 July 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Advances in vaccine delivery: transcutaneous immunisation

20 July 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

The LTR72 mutant of heat-labile enterotoxin of Escherichia coli enhances the ability of peptide antigens to elicit CD4(+) T cells and secrete gamma interferon after coapplication onto bare skin

20 July 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Topical TLR9 agonists induce more efficient cross-presentation of injected protein antigen than parenteral TLR9 agonists do

20 July 2024

148

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG-oligodeoxynucleotides

20 July 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod

20 July 2024

150

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Topical resiquimod promotes priming of CTL to parenteral antigens

20 July 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice

20 July 2024

152

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration

20 July 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety

20 July 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults

20 July 2024

156

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Dose sparing with intradermal injection of influenza vaccine

20 July 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system.

20 July 2024

158

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial

20 July 2024

159

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Two-dimensional elastic properties of human skin in terms of an incremental model at the in vivo configuration

20 July 2024

162

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system

20 July 2024

163

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Microinfusion using hollow microneedles

20 July 2024

164

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Mechanism of fluid infusion during microneedle insertion and retraction.

20 July 2024

165

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force.

20 July 2024

166

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transdermal drug delivery

20 July 2024

167

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Microneedle-based vaccines

20 July 2024

168

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery

20 July 2024

169

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Flux across [corrected] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro

20 July 2024

170

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method.

20 July 2024

171

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transcutaneous immunization studies in mice using diphtheria toxoid-loaded vesicle formulations and a microneedle array

20 July 2024

172

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy

20 July 2024

173

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Skin penetration enhancement by a microneedle device (Dermaroller) in vitro: dependency on needle size and applied formulation

20 July 2024

174

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization

20 July 2024

176

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Coated microneedles for transdermal delivery

20 July 2024

177

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge

20 July 2024

178

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine

20 July 2024

179

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transdermal influenza immunization with vaccine-coated microneedle arrays

20 July 2024

180

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin

20 July 2024

181

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model

20 July 2024

182

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

The effect of strain rate on the precision of penetration of short densely-packed microprojection array patches coated with vaccine

20 July 2024

183

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Improved influenza vaccination in the skin using vaccine coated microneedles

20 July 2024

184

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Coating formulations for microneedles

20 July 2024

186

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity

20 July 2024

187

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Side-opened out-of-plane microneedles for microfluidic transdermal liquid transfer

20 July 2024

188

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Precise microinjection into skin using hollow microneedles.

20 July 2024

189

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

In vivo evaluation of a microneedle-based miniature syringe for intradermal drug delivery.

20 July 2024

191

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery.

20 July 2024

194

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Sugar micro needles as transdermic drug delivery system

20 July 2024

198

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Feasibility of microneedles for percutaneous absorption of insulin.

20 July 2024

199

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Self-dissolving microneedles for the percutaneous absorption of EPO in mice

20 July 2024

200

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Polymer microneedles for controlled-release drug delivery.

20 July 2024

201

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Characterization of solid maltose microneedles and their use for transdermal delivery

20 July 2024

202

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Dissolving microneedles for transdermal drug delivery

20 July 2024

203

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

In vitro transdermal delivery of therapeutic antibodies using maltose microneedles

20 July 2024

204

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Processing difficulties and instability of carbohydrate microneedle arrays.

20 July 2024

205

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Dissolving polymer microneedle patches for influenza vaccination

20 July 2024

206

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Minimally invasive protein delivery with rapidly dissolving polymer microneedles

20 July 2024

207

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge.

20 July 2024

209

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin.

20 July 2024

210

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Micro-scale devices for transdermal drug delivery

20 July 2024

212

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum

20 July 2024

213

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.

20 July 2024

214

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transcutaneous immunization: a human vaccine delivery strategy using a patch

20 July 2024

215

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.

20 July 2024

216

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Water Distribution and Related Morphology in Human Stratum Corneum at Different Hydration Levels

20 July 2024

217

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice.

20 July 2024

218

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Low-frequency ultrasound as a transcutaneous immunization adjuvant

20 July 2024

219

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization

20 July 2024

220

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses

20 July 2024

221

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Epidermal powder immunization with a recombinant HIV gp120 targets Langerhans cells and induces enhanced immune responses

20 July 2024

222

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Epidermal powder immunization of mice and monkeys with an influenza vaccine

20 July 2024

223

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device.

20 July 2024

224

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Epidermal DNA vaccine for influenza is immunogenic in humans

20 July 2024

225

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Preclinical safety assessment of a DNA vaccine using particle-mediated epidermal delivery in domestic pig, minipig and mouse

20 July 2024

226

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients.

20 July 2024

227

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Multi-antigenic DNA immunization using herpes simplex virus type 2 genomic fragments

20 July 2024

228

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial

20 July 2024

229

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

An outbreak of hepatitis B associated with jet injections in a weight reduction clinic

20 July 2024

230

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Immunization without needles

20 July 2024

231

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine

20 July 2024

232

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch

20 July 2024

233

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch

20 July 2024

235

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Needle-free skin patch vaccination method for anthrax

20 July 2024

236

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial

20 July 2024

237

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans

20 July 2024

238

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Induction of therapeutically relevant cytotoxic T lymphocytes in humans by percutaneous peptide immunization.

20 July 2024

239

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice.

20 July 2024

240

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Persistent antibody and T cell responses induced by HIV-1 DNA vaccine delivered by electroporation

20 July 2024

241

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques

20 July 2024

242

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Effect of tape stripping and adjuvants on immune response after intradermal DNA electroporation

20 July 2024

243

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

20 July 2024

244

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes

20 July 2024

245

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Strong HIV-specific CD4+ and CD8+ T-lymphocyte proliferative responses in healthy individuals immunized with an HIV-1 DNA vaccine and boosted with recombinant modified vaccinia virus ankara expressing HIV-1 genes

20 July 2024

246

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys

20 July 2024

247

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Protection of mice against rotavirus challenge following intradermal DNA immunization by Biojector needle-free injection

20 July 2024

248

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery

20 July 2024

249

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Particle-based vaccines for transcutaneous vaccination

20 July 2024

250

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens

20 July 2024

251

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses

20 July 2024

252

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes

20 July 2024

253

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines

20 July 2024

254

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes

20 July 2024

255

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier

20 July 2024

257

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transfersomes for transdermal drug delivery

20 July 2024

258

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies

20 July 2024

259

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transfersomes—A Novel Vesicular Carrier for Enhanced Transdermal Delivery: Development, Characterization, and Performance Evaluation

20 July 2024

260

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro

20 July 2024

261

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transdermal immunization with large proteins by means of ultradeformable drug carriers

20 July 2024

262

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes

20 July 2024

263

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study

20 July 2024

264

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Elastic liposomes mediated transcutaneous immunization against Hepatitis B

20 July 2024

265

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Structure of the skin barrier and its modulation by vesicular formulations

20 July 2024

267

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Skin penetration and mechanisms of action in the delivery of the D2-agonist rotigotine from surfactant-based elastic vesicle formulations

20 July 2024

268

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo

20 July 2024

270

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes

20 July 2024

271

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Mannosylated niosomes as carrier adjuvant system for topical immunization

20 July 2024

272

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transcutaneous delivery of a nanoencapsulated antigen: induction of immune responses

20 July 2024

273

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transcutaneous vaccination with virus-like particles

20 July 2024

274

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.

20 July 2024

275

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex

20 July 2024

276

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Chemical conjugate TMV-peptide bivalent fusion vaccines improve cellular immunity and tumor protection.

20 July 2024

277

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations.

20 July 2024

278

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination

20 July 2024

279

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Multiphoton high-resolution 3D imaging of Langerhans cells and keratinocytes in the mouse skin model adopted for epidermal powdered immunization

20 July 2024

280

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Disappearance of epidermal Langerhans cells during PUVA therapy

20 July 2024

281

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

The influence of epidermal thickness on transcutaneous oxygen pressure measurements in normal persons.

20 July 2024

282

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Gender differences in mouse skin morphology and specific effects of sex steroids and dehydroepiandrosterone

20 July 2024

283

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

Transfollicular drug delivery

20 July 2024

284

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.018

20 July 2024

Identifiers

1 reference

23 August 2017

1 reference